Study Stopped
Futility
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute, Ischemic Stroke
1 other identifier
interventional
277
10 countries
100
Brief Summary
The primary purpose of this study is to determine whether a brief intravenous infusion of ancrod started within 6 hours of stroke onset improves functional outcome at 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 stroke
Started Sep 2005
100 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2005
CompletedFirst Posted
Study publicly available on registry
September 1, 2005
CompletedStudy Start
First participant enrolled
September 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedDecember 23, 2009
December 1, 2009
3.3 years
August 30, 2005
December 21, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Responder analysis based on Modified Rankin Scale (mRS)
90 days
Secondary Outcomes (1)
National Institute of Health Stroke Scale (NIHSS),Barthel Index (BI),Fibrinogen levels with ancrod tx, and Safety of ancrod tx
90 days
Study Arms (2)
Intravenous ancrod
EXPERIMENTALIntravenous ancrod infused at a rate of 0.167 IU/kg/hr (0.6 mL/kg/hr) for 2 or 3 hours depending on the pretreatment fibrinogen level.
Intravenous Placebo
PLACEBO COMPARATORIntravenous placebo at a rate of 0.6 mL/kg/hr for 2 or 3 hours depending on the pretreatment fibrinogen level.
Interventions
Eligibility Criteria
You may qualify if:
- Acute, ischemic stroke with first symptoms within 6 hours of beginning treatment
- Baseline NIHSS \> 5
You may not qualify if:
- No intracranial, extravascular blood on CT
- Hypertension (systolic \> 185; diastolic \> 105)
- Baseline fibrinogen level \< 100 mg/dL
- Thrombocytopenia (\< 100,000 / mm3)
- Recent (\< 3 days) or anticipated (\< 5 days) use of a thrombolytic agent
- Recent (\< 14 days) or anticipated surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (100)
Mayo Clinic Hospital / Arizona
Phoenix, Arizona, 85054, United States
Sparks Regional Medical Center
Fort Smith, Arkansas, 72901, United States
Loma Linda University School of Medicine
Loma Linda, California, 92354, United States
Santa Monica - UCLA Medical Center
Los Angeles, California, 90024, United States
UCLA Medical Center
Los Angeles, California, 90024, United States
Hoag Memorial Hospital
Newport Beach, California, 92658, United States
The Neurology Center: Tri-City Medical Center
Oceanside, California, 92056, United States
Shasta Regional Medical
Redding, California, 96001, United States
Bridgeport Hospital
Bridgeport, Connecticut, 06610, United States
Neurologic Consultants, P.A.
Fort Lauderdale, Florida, 33308, United States
Shands Jacksonville / University of Florida
Jacksonville, Florida, 32209, United States
Ocala Neurodiagnostic Center
Ocala, Florida, 34471, United States
Florida Hospital Neuroloscience Institute
Orlando, Florida, 32804, United States
Fawcett Memorial Hospital
Port Charlotte, Florida, 33952, United States
Peace River Regional Medical Center
Port Charlotte, Florida, 33952, United States
Tallahassee Memorial Healthcare, Inc.
Tallahassee, Florida, 32303, United States
The Queens Medical Center, Neuroscience Institute
Honolulu, Hawaii, 96813, United States
Mercy Hospital
Chicago, Illinois, 60616, United States
Elkhart Clinic, LLC - Neurology
Elkhart, Indiana, 46514, United States
Fort Wayne Neurological Center
Fort Wayne, Indiana, 46804, United States
Parkview Research Center
Fort Wayne, Indiana, 46805, United States
Sinai Hospital of Baltimore
Baltimore, Maryland, 21215, United States
Baystate Medical Center
Springfield, Massachusetts, 01199, United States
Wayne State University
Detroit, Michigan, 48201, United States
St. Mary's Duluth Clinic
Duluth, Minnesota, 55805, United States
Minneapolis Clinic of Neurology
Golden Valley, Minnesota, 55422, United States
Deaconess Billings Clinical Research Center
Billings, Montana, 59101, United States
NJ Neuroscience Institute
Edison, New Jersey, 08818, United States
Neurology Consultants Of Burlington County
Lumberton, New Jersey, 08048, United States
UMDNJ / Robert Wood Johnson Medical School
New Brunswick, New Jersey, 08901, United States
Neurology Group of Bergen County
Ridgewood, New Jersey, 07450, United States
Shore Neurology
Toms River, New Jersey, 08755, United States
Kaleida Stroke Center
Buffalo, New York, 14209, United States
United Health Services Hospitals
Johnson City, New York, 13790, United States
Winthrop University Hospital
Minneola, New York, 11501, United States
Weill Medical College of Cornell University
New York, New York, 10021, United States
Rochester General Hospital
Rochester, New York, 14621, United States
Strong Memorial Hospital
Rochester, New York, 14642, United States
Presbyterian Hospital
Charlotte, North Carolina, 28204, United States
Lebauer Cardiovascular Research Foundation at Moses Cone Hospital
Greensboro, North Carolina, 27401, United States
Clinical Research of Winston-Salem
Winston-Salem, North Carolina, 27103, United States
The Toledo Hospital
Toledo, Ohio, 43606, United States
Medical University of Ohio
Toledo, Ohio, 43614, United States
Northshore Clinical Associates
Erie, Pennsylvania, 16507, United States
Westmoreland Neurology Associates, Inc.
Greensburg, Pennsylvania, 15601, United States
Miriam Hospital
Providence, Rhode Island, 02906, United States
Beaufort Memorial Hospital
Beaufort, South Carolina, 34205, United States
Methodist University Hospital
Memphis, Tennessee, 38104, United States
Brackenridge Hospital
Austin, Texas, 78701, United States
Seton Medical Center
Austin, Texas, 78705, United States
Methodist Hospital / Neurological Institute
Houston, Texas, 77030, United States
University of Texas Health Sciences Center
San Antonio, Texas, 78229, United States
Virginia Commonwealth University
Richmond, Virginia, 23219, United States
Neurological Consultants of Virginia Beach
Virginia Beach, Virginia, 23454, United States
Harborview Medical Center
Seattle, Washington, 98104, United States
Madigan Army Medical Center
Tacoma, Washington, 98431, United States
St. Lukes Medical Center
Milwaukee, Wisconsin, 53215, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Gosford Hospital Department of Neurology
Gosford, New South Wales, 2250, Australia
Flinders Medical Centre
Bedford Park, South Australia, 5042, Australia
Box Hill Hospital
Box Hill, Victoria, Australia
National Stroke Research Institute
Heidelberg Heights, Victoria, 3081, Australia
Grey Nuns Community Hospital
Edmonton, Alberta, 1100, Canada
Western Memorial Health Clinic
Corner Brook, Newfoundland and Labrador, A2H 4B8, Canada
London Health Sciences Centre - University Hospital
London, Ontario, Canada
Trillum Health Centre
Mississauga, Ontario, L5B1B8, Canada
Hospital Charles-Leymoyne
Greenfield Park, Quebec, J4V2h1, Canada
University of Alberta Hospital
Edmonton, T6G2B7, Canada
Thunder Bay Regional Health Sciences Centre
Thunder Bay, P7B7C7, Canada
St. Anne's Faculty Hospital
Brno, 65691, Czechia
Faculty Hospital 1, The Clinic of Neurology
Pilsen, 30460, Czechia
St. Anna Hospital
Geldrop, 5660 AB, Netherlands
University Clinical Hospital
Warsaw, 02-097, Poland
City Hospital #31
Moscow, 119415, Russia
Research Institute of Neurology RAMS
Moscow, 125367, Russia
Military Medical Akademy Dept of Neurology
Saint Petersburg, 194044, Russia
St. Augustine's Hospital
Berea, Durban, KwaZulu-Natal, 4001, South Africa
Tiervlei Trial Centre
Cape Town, 7536, South Africa
Vergelegen Medi-Clinic
Somerset West, 7130, South Africa
Sunninghill Hospital
Sunninghill, 2157, South Africa
Changhua Christian Hospital, Chief Department of Neurology
Changhua, 50022, Taiwan
Lo-Tung Pohai Hospital, Department of Neurology
IIan, 265, Taiwan
Chung-Ho Memorial Hospital Kaohsiung Medical University
Kaohsiung City, 807, Taiwan
Kaohsiung Chang-Gung, Memorial Hospital
Kaohsiung City, 83305, Taiwan
Chung Shan Medical Hospital
Taichung, 402, Taiwan
China Medical University Hospital
Taichung, 404, Taiwan
Taichung Veterans General Hospital, Section of Neurology
Taichung, 407, Taiwan
Kuang-Tien General Hospital
Taichung, 433, Taiwan
Chi-Mei Medical Center
Tainan, 710, Taiwan
National Taiwan University Hospital
Taipei, 100, Taiwan
Cathay General Hospital Department of Neurology
Taipei, 11073, Taiwan
Shin-Kong WHS Memorial Hospital
Taipei, 111, Taiwan
Tri-Service General Hospital
Taipei, 114, Taiwan
Far Eastern Memorial Hospital
Taipei, 220, Taiwan
En Chu Kong Hospital
Taipei, 23702, Taiwan
Chang-Gung Memorial Hospital Linko Medical Center
Taoyuang, 333, Taiwan
Chang-Gung Memorial Hospital, Linko Medical Center
Taoyuang, 333, Taiwan
University of Aberdeen, Polwarth Building, Institute of Medical Sciences, Dept. of Medicine & Theropeutics
Aberdeen, AB252ZD, United Kingdom
Institute of Neurological Sciences Southern General Hospital
Glasgow, G514TF, United Kingdom
Royal Victoria Infirmary - Clinical Research Center
Newcastle, United Kingdom
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Warren Wasiewski, M.D.
Neurobiological Technologies
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 30, 2005
First Posted
September 1, 2005
Study Start
September 1, 2005
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
December 23, 2009
Record last verified: 2009-12